期刊文献+

大鼠肾脏异丙酚代谢相关ugt1a6基因在无肝期表达变化的研究 被引量:9

Study of gene expression variation of rat kidney ugt1a6 related to propofol metabolism in anhepatic phase
下载PDF
导出
摘要 目的研究无肝期前后与异丙酚代谢相关的尿苷二磷酸葡萄糖醛酸转移酶ugt1a6在大鼠肾脏中的基因表达变化,初步阐释异丙酚无肝期肝外代谢特点形成的原因。方法15只雄性大鼠随机分为3组(5只/组),A组为对照组,B组阻断肝门30 m in,C组阻断肝门60 m in,截取各组大鼠肾脏组织,采用逆转录聚合酶链式反应(RT-PCR)技术,检测各组ugt1a6 mRNA的表达。结果大鼠肾脏组织ugt1a6的基因表达水平B、C组明显高于A组(P<0.05);B组与C组相比,无显著差异(P>0.05)。结论大鼠肾脏组织ugt1a6基因表达在无肝期比无肝期前增多,这可能是异丙酚无肝期肝外代谢增强的机制之一。 Objective To investigate the gene expression variation of rat kidney uridine diphosphate glucuronatetransferase ugtla6 related to propofol metabolism in anhepatic phase and to primarily explain the reasons of extrahepatic metabolism characteristic of propofol. Methods A total of 15 male SD rats were distributed randomly to 3 groups ( n = 5 in each group) : control group ( group A) , devascularization of the hepatic portal for 30 min (group B) and 60 min (group C). Kidney tissues of rats were taken and ugtla6 mRNA were detected by RT-PCR. Results Gene expression levels of kidney ugtla6 of groups B and C were significantly higher than group A ( P 〈 0. 05 ). The gene expression levels between B and C were of no significant difference. Conclusion Gene expression levels of kidney ugtl a6 of rats increased in anhepatic phase as compared with the phase of hepatic portal dissociation, which is one of the possible reasons that extrahepatic metabolism of propofol is increased in anhepatic phase.
出处 《第三军医大学学报》 CAS CSCD 北大核心 2005年第16期1697-1699,共3页 Journal of Third Military Medical University
基金 第三军医大学中青年科研基金资助项目(2004)~~
关键词 异丙酚 尿苷二磷酸葡萄糖醛酸转移酶 无肝期 基因 propofol uridine diphosphate glucuronyhransferase anhepatic phase gene
  • 相关文献

参考文献9

  • 1Veroli P, O' Kelly B, Bertrand F, et al. Extrahepatic metabolism of propofol in man during the anhepatic phase of orthotopic liver transplantation[J]. Br J Anaesth, 1992, 68(2): 183 - 186.
  • 2Le Guellec C, Lacarelle B, Villard P H, et al. Glucuronidation of propofol in microsomal fractions from various tissues and species including humans: effect of different drugs[J]. Anesth Analg, 1995, 81(4):855-861.
  • 3朱益贫,杨立群,俞卫锋.小儿肝移植无肝期丙泊酚的药代动力学特点[J].第二军医大学学报,2001,22(9):875-877. 被引量:8
  • 4Ethell B T, Ekins S, Wang J, et al. Quantitative structure activity relationships for the glucuronidation of simple phenols by expressed human ugt1α6 and UGT1A9[J]. Drug Metab Dispos, 2002, 30(6):734 - 738.
  • 5Raoof A A, van Obbergh L J, de Ville de Goyet J, et al. Extrahepatic glucuronidation of propofol in man: possible contribution of gut wall and kidney[J]. Eur J Clin Pharmacol, 1996, 50(1 -2): 91 -96.
  • 6李新.人体内的葡醛酸结合反应及其影响因素[J].中国临床药理学杂志,2002,18(5):387-395. 被引量:7
  • 7Gueraud F, Daveloose D, Vezin H, et al. In vivo modification of the UDP-glucuronosyltransferase functional state in rat liver following hypophysectomy and partial or complete hormonal restoration [ J ]. J Biochem (Tokyo), 2003, 134(5): 641 -653.
  • 8Hiroshi Y, Yohko K, Yasuko S, et al. Effects on extrahepatic UDPglucuronosyltransferases in hypophysectomized rat[ J]. J Biochem (Tokyo), 2002, 132(2): 265 -270.
  • 9Shelby M K, Cherrington N J, Vansell N R, et al. Tissue mRNA expression of the rat UDP-glucuronosyltransferase gene family [ J ]. Drug Metab Dispos, 2003, 31 (3): 326 -333.

二级参考文献44

  • 1贺平.有关安替比林代谢的临床药理研究[J].中国药理学通报,1996,21(4):306-309. 被引量:7
  • 2傅丽红,冉国侠,许伟彬,卡哈尔,逢全,焦士林,曹泽兵.异丙酚临床药物动力学研究[J].中国医院药学杂志,1997,17(2):51-53. 被引量:17
  • 3[23]McGurk KA, Brierley CH, Burchell B. Drug glucuronidation by human renal UDP-glucuronosyltransferases. Biochem Pharmacol,1998;55:1005~1012
  • 4[24]Lampe JW, Bigler J, Bush AC, et al. Prevalence of polymorphisms in the human UDP-glucuronosyltransferase 2B family: UGT2B4(D458E), UGT2B7(H268Y), and UGT2B15(D85Y). Cancer Epidemiol Biomarkers Prey,2000; 9:329~333.
  • 5[25]Levesque E, Beaulieu M, Green MD, et al. Isolation and characterization of UGT2B 15(Y85): a UDP-glucuronosyltransferase encoded by a polymorphic gene.Pharmacogenetics,1997; 7: 317~325.
  • 6[26]Belanger A, Hum DW, Beaulieu M, et al. Characterization and regulation of UDP-glucuronosyltransferases in steroid target tissues.J Steroid Biochem Mol Bio1,1998; 65: 301~310.
  • 7[27]Brown SY, Garland WA, Fukuda EK. Isolation and characterization of an unusual glucuronide conjugate of rimantadine. Drug Metab Dispos, 1990; 18: 546~547.
  • 8[28]Burchell B and Coughtrie MWH. UDP-glucuronosyltransferases.Pharm Ther, 1989:261~289.
  • 9[29]Bock KW, Gschaidmeier H, Heel H, et al. Functions and transcriptional regulation of PAH-inducible human UDP-glucuronosyltransferases. Drug Metabolism Reviews, 1999;31:411~422.
  • 10[30]Bock KW, Gschaidmeier H, Heel H, et al. AH receptor-controlled transcriptional regulation and function of rat and human UDPglucuronosyltransferase isoforms. Adv Enzyme Regul, 1998: 38207-38222.

共引文献11

同被引文献90

引证文献9

二级引证文献24

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部